Because no antibodies are available so far which recognise survivin-2B and survivin-ΔEx3, we could only analyse the expression of survivin protein in four arbitrarily selected gastric carcinoma samples that represent the UICC stages I to IV. Here, BIRC5 is linked to gastric carcinoma.